LARVAL DEBRIDEMENT THERAPY PRODUCTS - LARVAE 100/200/300 AND BIOBAG 50/100/200/300/400

Maggots, Medical

BIOMONDE

The following data is part of a premarket notification filed by Biomonde with the FDA for Larval Debridement Therapy Products - Larvae 100/200/300 And Biobag 50/100/200/300/400.

Pre-market Notification Details

Device IDK142020
510k NumberK142020
Device Name:LARVAL DEBRIDEMENT THERAPY PRODUCTS - LARVAE 100/200/300 AND BIOBAG 50/100/200/300/400
ClassificationMaggots, Medical
Applicant BIOMONDE 62 FOREST STREET, STE 300 Marlborough,  MA  01752
ContactRosina Robinson, Rn, Med, Rac
CorrespondentRosina Robinson, Rn, Med, Rac
BIOMONDE 62 FOREST STREET, STE 300 Marlborough,  MA  01752
Product CodeNQK  
CFR Regulation Number510(k) Premarket Notification [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2014-07-25
Decision Date2014-11-05
Summary:summary

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.